States Chronicle - Latest Breaking World News

Saturday, March 6, 2021
Log in
  • About Us
  • Contact Us
  • Authors
  • Investor Relations
  • Privacy
  • Terms of Use
  • Latest News
    • Right Colors for your Skin Tone
    • MOST ACTIVE NASDAQ After-Hours
    • iPhone 5C Release Date
    • Samsung Galaxy S5 Release Date
    • The History of the Atkins Diet

Abbvie’s Venetoclax Opens New Ways Of Treating AML

December 9, 2014 By Georgia Dawson Leave a Comment

Email, RSS Follow

Abbvie’s Venetoclax Opens New Ways Of Treating AMLA new clinical trial on patients suffering from acute myelogenous leukemia (AML) using Abbvie’s venetoclax opens up new ways of treating AML.

Abbvie released the results from a Phase 2 investigation of venetoclax (ABT-199/GDC-0199) in patients with acute myelogenous leukemia (AML). These were made public in a discourse at the 56th Annual Meeting of the American Society of Hematology.

The Phase 2 open-brand clinical trial was intended to assess the preparatory viability of venetoclax in 32 patients with backslid/unmanageable AML or as cutting edge help for patients who are unfit for intensive therapy. AML is a forceful and destructive sort of blood tumor, in which the body creates an excess of a particular kind of white platelet (myeloblast), which can swarm out solid platelets. ALM has very low survival rates, being a very destructive to the human body.

Results exhibited a general reaction rate (ORR) of 15.5% in patients taking the drug, with one patient accomplishing a complete reaction and four attaining a complete reaction with deficient blood number recuperation.

A complete reaction (CR) or as frequently called- a complete remission, means that all the symptoms of the disease vanished as a response to a specific cure.

A complete reaction with inadequate blood tally recuperation (Cri) is the point at which a patient satisfies most – yet not all – criteria to be considered a complete reaction.

According to Marina Konopleva at the University of Texas MD Anderson Cancer Center,  patients suffering from ALM are really in need of new and improved alternative therapies and the outcomes of the study are endowing and guarantee there will be future trials in this area.

Gary Gordon vice president, oncology clinical development, AbbVie also noted that this was the first time when the company reported results from the venetoclax Phase 2 clinical tests in patients with AML.

He pledged that the company he represents will continue to be dedicated to finding new and improved therapy alternatives as this trial shows AbbVie’s perpetual advancement in the programs involving blood cancer.

Venetoclax is an investigational inhibitor of the B-cell lymphoma-2 (BCL-2) protein, which anticipates apoptosis of a few cells, including lymphocytes.

This is not the only study concerning this type of leukemia that has recently been published. Subsequently, the journal Nature distributed this week the results of another study undertaken at Washington University School of Medicine in St. Louis.

Basically, scientists there performed a complete genome sequencing on 22 subject samples from persons suffering from AML. The results showed that genetic errors connected to aging may lead to leukemia that develops after cancer treatment.

In the United States around 18,000 cases of AML are discovered annually and approximately 2,000 of them occur past chemotherapy or radiation treatments.

Email, RSS Follow

Filed Under: Health Tagged With: AbbVie Announces Phase 2 Results for AML Treatment, BCL-2 Inhibitor Venetoclax Demonstrates Activity in Pretreated AML, Genetic errors linked to aging underlie leukemia that develops after cancer treatment, Sequencing Study Suggests Mutation Selection Behind Glitches in Therapy-related AML, Venetoclax Achieves Complete Response in Acute Myelogenous Leukemia Study

About Georgia Dawson

What Georgia best loves about journalism is the intricacies of covering a story. Following a lead, talking to people or conducting under-the-hood investigations is what fuels Georgia’s drive for this profession.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 30 other subscribers

Doom and MiniDoom 2

Volunteer-Based Mexican Studio Releases Sidescrolling Doom Clone

March 12, 2018 By Georgia Dawson Leave a Comment

Chinese Mom and locked iPhone.

Toddler Locks Chinese Mom Out of Phone for Half a Century

March 9, 2018 By James Faulkner Leave a Comment

Alexa laughing

Amazon Alexa Laughing out of the Blue Puzzles Engineers

March 8, 2018 By Jack M. Robinson Leave a Comment

Flippy and the Burgers

Meet Flippy, World’s First Fast-Food Robotic Chef

March 6, 2018 By Georgia Dawson Leave a Comment

System Shock

System Shock Remastered Delayed, Nightdive Studios CEO Announces

February 19, 2018 By Janet Vasquez Leave a Comment

Sea of Thieves.

Sea of Thieves Optimized for Low-End PCs

February 14, 2018 By Georgia Dawson Leave a Comment

Sony and VR

Sony Touts New Generation of VR Controllers

January 31, 2018 By Deborah Cobing Leave a Comment

YouTube

YouTube Stiffens Its Monetization Policy to Discourage Spammers and Bad Actors

January 18, 2018 By Georgia Dawson Leave a Comment

Google Art Doppelganger

Google App Can Now Show Your Art Doppelganger

January 15, 2018 By Troy Rubenson Leave a Comment

YouTube mobile app logo on a smartphone

YouTube Now Enables Vertical Videos on iOS

December 24, 2017 By Janet Vasquez Leave a Comment

Samsung Galaxy S2 with a shattered screen

Cracked Smartphone Screens Are a Thing of the Past – Self-Healing Polymer Gets Fixed Just by Pressing It

December 20, 2017 By Janet Vasquez Leave a Comment

Bing logo on a white background

Bing Improves Its Search Results with the Help of AI and Reddit Integration

December 16, 2017 By Janet Vasquez Leave a Comment

White hashtag on a blue background

Follow Your Interests on Instagram by Directly Following Hashtags

December 14, 2017 By Janet Vasquez Leave a Comment

Samsung Galaxy S7 Edge on a leather seat

Samsung Galaxy Smartphones Make More People Happier as Compared to iPhones

December 13, 2017 By Janet Vasquez Leave a Comment

Related Articles

  • image of retina

    Laser Pointer Makes Hole in Little Boy’s Retina

    Jun 21, 2018
  • person playing a video game

    World Health Organization Officially Recognizes Gaming Disorder

    Jun 19, 2018
  • two robot hands

    Sex Robots Don’t, In Fact, Provide Any Heath Benefits (Study)

    Jun 6, 2018
  • women's health initiative logo

    Some Breast Cancer Patients Can Skip Chemotherapy (Study)

    Jun 4, 2018
  • bowl of vitamin supplements

    Vitamin and Mineral Supplements are Useless (Study)

    May 31, 2018
  • two cockroaches on a leaf

    Cockroach Milk, The Latest Superfood Trend

    May 29, 2018
  • seafood on platter

    Seafood Boosts Libido and Fertility (Study)

    May 25, 2018
  • Vitamin D pills

    Vitamin D Therapy to Treat Diabetes and Cancer (Study)

    May 14, 2018
  • woman with a runny nose

    Woman’s Runny Nose Was Actually Brain Fluid Leak

    May 8, 2018
  • children running

    Children are in Better Shape than Athletes (Study)

    Apr 25, 2018

Categories

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Markets
  • National News
  • Nature
  • News
  • Politics
  • Science
  • Technology
  • Uncategorized
  • World

Copyright © 2021 statechronicle.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.